FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R.
Chiodelli P, et al. Among authors: ronca r.
Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1.
Cancer Lett. 2022.
PMID: 34861311